Lacidipine: Beyond Hypertension-Cardiovascular, Neuroprotective, and Renoprotective Effects

dc.contributor.authorSoumarshi Das
dc.contributor.authorPrabir Maity
dc.contributor.authorAnjali Sharma
dc.contributor.authorSarita Jangra
dc.date.accessioned2026-10-07T10:06:37Z
dc.date.available2026-10-07T10:06:37Z
dc.date.issued2026-01-29
dc.description.abstractBackground: Hypertension remains a leading contributor to cardiovascular, cerebrovascular, and renal disease worldwide. While calcium channel blockers are well established for blood pressure management, growing attention is being given to agents that provide organ protection beyond hemodynamic control. Lacidipine, a highly lipophilic dihydropyridine calcium channel blocker, shows strong membrane affinity and antioxidant properties, suggesting potential benefits that extend beyond its antihypertensive role. Purpose: This review critically examines lacidipine’s therapeutic profile by integrating evidence of its vascular, cardiovascular, neurovascular, and renal protective effects alongside its established clinical use. Methods: A comprehensive analysis of preclinical studies, clinical trials, and mechanistic reports was conducted to examine lacidipine’s pharmacological properties, antioxidant activity, and vasoprotective roles beyond blood pressure control. Results: Lacidipine exhibits pronounced vascular selectivity and sustained activity with good tolerability in clinical use. Experimental studies demonstrate antioxidant and anti-inflammatory effects that mitigate endothelial dysfunction, vascular remodeling, and oxidative injury. Clinical evidence supports its efficacy is comparable to other major antihypertensive classes. Emerging data further indicate neuroprotective effects in models of stroke and neurodegeneration, renoprotective actions through improved microvascular and glomerular function, and cardioprotective benefits including attenuation of left ventricular hypertrophy and atherosclerotic progression. Conclusions: Beyond effective blood pressure management, lacidipine shows multi organ protective properties that may enhance long term outcomes in hypertension associated disorders. Further studies are warranted to validate these benefits in clinical settings and to explore repositioning strategies that leverage its pleiotropic therapeutic potential.
dc.identifier.issn2321-2217
dc.identifier.issn2321-2225
dc.identifier.otherhttps://doi.org/10.15415/jptrm.2025.132001
dc.identifier.urihttps://dspace.chitkara.edu.in/handle/123456789/722
dc.language.isoen
dc.publisherChitkara University Publications
dc.subjectLacidipine
dc.subjectCalcium antagonist
dc.subjectHypertension
dc.subjectAtherosclerosis
dc.subjectNeuroprotection
dc.subjectCardiovascular disease
dc.titleLacidipine: Beyond Hypertension-Cardiovascular, Neuroprotective, and Renoprotective Effects
dc.typeArticle

Files